LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $56,000 | -57.9% | 10,000 | -50.0% | 0.00% | -100.0% |
| Q4 2018 | $133,000 | -37.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $213,000 | -6.6% | 20,000 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $228,000 | +51.0% | 19,000 | +8.0% | 0.00% | 0.0% |
| Q1 2018 | $151,000 | -13.2% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $174,000 | -19.4% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $216,000 | -25.5% | 17,600 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $290,000 | +15.1% | 17,600 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $252,000 | +3.7% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $243,000 | -23.6% | 17,600 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $318,000 | +16.1% | 17,600 | -7.9% | 0.00% | 0.0% |
| Q2 2016 | $274,000 | +20.2% | 19,100 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $228,000 | -10.2% | 19,100 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $254,000 | +66.0% | 19,100 | +33.7% | 0.00% | +100.0% |
| Q3 2015 | $153,000 | +33.0% | 14,285 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $115,000 | – | 14,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |